Kang HG - Search Results

1

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.

Lee DH, Kim GW, Yoo J, Lee SW, Jeon YH, Kim SY, Kang HG, Kim DH, Chun KH, Choi J, Kwon SH. Lee DH, et al. Among authors: kang hg. Cell Death Dis. 2021 Jan 18;12(1):89. doi: 10.1038/s41419-020-03380-2. Cell Death Dis. 2021. PMID: 33462212 Free PMC article.

2

HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53.

Yi SA, Lee DH, Kim GW, Ryu HW, Park JW, Lee J, Han J, Park JH, Oh H, Lee J, Choi J, Kim HS, Kang HG, Kim DH, Chun KH, You JS, Han JW, Kwon SH. Yi SA, et al. Among authors: kang hg. Cell Death Differ. 2020 Sep;27(9):2537-2551. doi: 10.1038/s41418-020-0520-5. Epub 2020 Mar 23. Cell Death Differ. 2020. PMID: 32203172 Free PMC article.

3

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.

Cho Y, Lee HW, Kang HG, Kim HY, Kim SJ, Chun KH. Cho Y, et al. Among authors: kang hg. Oncotarget. 2015 Apr 20;6(11):8709-21. doi: 10.18632/oncotarget.3325. Oncotarget. 2015. PMID: 25909162 Free PMC article.

4

Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism.

La SH, Kim SJ, Kang HG, Lee HW, Chun KH. La SH, et al. Among authors: kang hg. Oncotarget. 2016 Aug 30;7(35):57117-57130. doi: 10.18632/oncotarget.10986. Oncotarget. 2016. PMID: 27494887 Free PMC article.

5

Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH. Cho Y, et al. Among authors: kang mj, kang hg. Cell Death Differ. 2018 Nov;25(10):1781-1795. doi: 10.1038/s41418-018-0079-6. Epub 2018 Mar 6. Cell Death Differ. 2018. PMID: 29511337 Free PMC article.

6

Correction to: Post-translational modification of OCT4 in breast cancer tumorigenesis.

Cho Y, Kang HG, Kim SJ, Lee S, Jee S, Ahn SG, Kang MJ, Song JS, Chung JY, Yi EC, Chun KH. Cho Y, et al. Among authors: kang mj, kang hg. Cell Death Differ. 2020 May;27(5):1743. doi: 10.1038/s41418-019-0439-x. Cell Death Differ. 2020. PMID: 31641242 Free PMC article.

7

Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.

Park EY, Chang E, Lee EJ, Lee HW, Kang HG, Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, Song E, Park JH. Park EY, et al. Among authors: kang hg. Cancer Res. 2014 Dec 15;74(24):7573-82. doi: 10.1158/0008-5472.CAN-14-1140. Epub 2014 Nov 3. Cancer Res. 2014. PMID: 25368020

8

A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.

Kim do Y, Park EY, Chang E, Kang HG, Koo Y, Lee EJ, Ko JY, Kong HK, Chun KH, Park JH. Kim do Y, et al. Among authors: kang hg. Oncotarget. 2016 Mar 22;7(12):14791-802. doi: 10.18632/oncotarget.7443. Oncotarget. 2016. PMID: 26895471 Free PMC article.

9

miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.

Son D, Kim Y, Lim S, Kang HG, Kim DH, Park JW, Cheong W, Kong HK, Han W, Park WY, Chun KH, Park JH. Son D, et al. Among authors: kang hg. Cancer Lett. 2019 Jul 10;454:224-233. doi: 10.1016/j.canlet.2019.04.006. Epub 2019 Apr 17. Cancer Lett. 2019. PMID: 31004703

10

Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer.

Kang HG, Kim WJ, Kang HG, Chun KH, Kim SJ. Kang HG, et al. Mol Cancer Res. 2020 Mar;18(3):403-413. doi: 10.1158/1541-7786.MCR-19-0811. Epub 2019 Dec 10. Mol Cancer Res. 2020. PMID: 31822520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

899 results

Search Page